Influenza and Other Respiratory Viruses,
Год журнала:
2022,
Номер
17(1)
Опубликована: Дек. 28, 2022
There
have
been
varying
reports
on
the
potential
occurrence
and
severity
of
changes
to
menstruation
including
median
cycle
length,
days
bleeding,
bleeding
heaviness,
menstrual
pain,
following
receipt
COVID-19
vaccinations.
We
aimed
assess
postvaccination
in
women
residing
Middle
East.We
implemented
a
cross-sectional
online
survey-based
study.
Data
about
participants'
demographic
characteristics,
experience,
vaccination
status
were
collected
analyzed
among
six
Arab
countries.Among
4942
menstruating
females
included
this
study,
who
had
received
one
or
more
doses
reported
higher
frequency
back
nausea,
tiredness,
pelvic
pain
with
periods,
unprescribed
analgesics
use,
passage
loose
stools.
They
also
scores
describing
average
worst
pain.
Fully
vaccinated
heavier
flow
bleeding.Our
findings
indicate
that
vaccine
may
an
effect
terms
heaviness.
The
evidence
needs
be
further
investigated
longitudinal
studies.
Human Reproduction Update,
Год журнала:
2022,
Номер
29(2), С. 177 - 196
Опубликована: Ноя. 14, 2022
In
2020,
SARS-CoV-2
and
the
COVID-19
pandemic
had
a
huge
impact
on
access
to
provision
of
ART
treatments.
Gradually,
knowledge
virus
its
transmission
has
become
available,
allowing
activities
resume.
Still,
questions
human
gametes
fertility
remain.
iScience,
Год журнала:
2023,
Номер
26(4), С. 106401 - 106401
Опубликована: Март 15, 2023
There
has
been
increasing
public
concern
that
COVID-19
vaccination
causes
menstrual
disturbance
regarding
the
relative
effect
of
compared
to
SARS-CoV-2
infection.
Our
objectives
were
test
potential
risk
factors
for
reporting
cycle
changes
following
and
compare
parameters
disease.
We
performed
a
secondary
analysis
retrospective
online
survey
conducted
in
UK
March
2021.
In
pre-menopausal
vaccinated
participants
(n
=
4,989),
18%
reported
after
their
first
vaccine
injection.
The
prevalence
any
was
higher
women
who
smoke,
have
history
disease,
or
are
not
using
estradiol-containing
contraceptives.
second
sample
including
both
unvaccinated
12,579),
alone
associated
with
abnormal
parameters,
while
disease
an
increased
heavier
bleeding,
"missed"
periods,
inter-menstrual
bleeding.
npj Digital Medicine,
Год журнала:
2022,
Номер
5(1)
Опубликована: Ноя. 2, 2022
COVID-19
vaccination
may
be
associated
with
change
in
menstrual
cycle
length
following
vaccination.
We
estimated
covariate-adjusted
differences
mean
(MCL),
measured
days,
between
pre-vaccination
cycles,
and
post-vaccination
cycles
within
vaccinated
participants
who
met
eligibility
criteria
the
Apple
Women's
Health
Study,
a
longitudinal
mobile-application-based
cohort
of
people
U.S.
manually
logged
cycles.
A
total
9652
(8486
vaccinated;
1166
unvaccinated)
contributed
128,094
(median
=
10
per
participant;
inter-quartile
range:
4-22).
Fifty-five
percent
received
Pfizer-BioNTech's
mRNA
vaccine,
37%
Moderna's
8%
Johnson
&
Johnson/Janssen
(J&J)
vaccine.
was
small
increase
MCL
for
which
first
dose
(0.50
95%
CI:
0.22,
0.78)
second
(0.39
0.11,
0.67)
vaccines
compared
Cycles
single
J&J
administered
were,
on
average,
1.26
days
longer
(95%
0.45,
2.07)
than
Post-vaccination
returned
to
average
length.
Estimated
follicular
phase
increased
(0.97
0.53,
1.42)
or
(1.43
1.06,
1.80)
(2.27
1.04,
3.50),
Menstrual
appears
temporary
should
not
discourage
individuals
from
becoming
vaccinated.
Climacteric,
Год журнала:
2022,
Номер
25(6), С. 570 - 578
Опубликована: Сен. 30, 2022
Midlife
women
commonly
experience
changes
in
their
cognitive
function
as
they
transition
through
menopause
and
express
concern
about
whether
these
represent
the
initial
stages
of
a
more
serious
disorder.
Health-care
practitioners
play
an
important
role
counseling
on
at
midlife
normalizing
women's
experience.
The
aim
this
commissioned
International
Menopause
Society
White
Paper
cognition
is
to
provide
with
overview
data
informing
clinical
care
menopausal
framework
for
decision-making.
Among
topics
presented
are
specific
occurring
menopause,
duration
such
severity.
estrogen
symptoms
reviewed.
We
present
talking
points
effects
hormone
therapy
dementia
risk
women,
including
discussion
absolute
risk.
Lastly,
brief
review
modifiable
factors
age-related
decline
presented,
guidance
patients
optimizing
brain
health
beyond.
BMJ Sexual & Reproductive Health,
Год журнала:
2024,
Номер
50(3), С. 212 - 225
Опубликована: Июнь 10, 2024
Menstrual
health
is
a
key
patient-reported
outcome
beyond
its
importance
as
general
indicator
of
and
fertility.
However,
menstrual
function
was
not
measured
in
the
clinical
trials
COVID-19
vaccines.
The
purpose
this
review
to
synthesise
existing
literature
on
relationship
between
vaccination
outcomes.
International Journal of Clinical Practice,
Год журнала:
2022,
Номер
2022, С. 1 - 5
Опубликована: Окт. 27, 2022
Several
factors
such
as
stress,
depression,
infection,
and
vaccination
influenced
the
menstrual
cycle
in
women
during
coronavirus
disease
2019
(COVID-19)
pandemic.
We
investigated
whether
there
were
changes
after
COVID-19
or
infection
and,
if
so,
nature
of
change.This
study
was
designed
a
descriptive,
cross-sectional
study.
A
face-to-face
survey
conducted
among
menstruating
aged
18-50
years
from
May
31
to
July
31,
2022.
Women
inquired
about
their
first
three
cycles
that
occurred
vaccination.Of
241
with
86
(35.7%)
mentioned
they
experienced
various
patterns
infection.
Of
537
participants
who
received
vaccines,
82
(15.1%)
stated
vaccination.
The
incidence
postvaccination
change
higher
Pfizer-BioNTech
Sinovac
(CoronaVac)
vaccines.
Only
10.9%
reported
pattern
consulted
physician.COVID-19
can
affect
women.
It
is
important
be
aware
warn
inform
this
issue.
Medicina,
Год журнала:
2024,
Номер
60(2), С. 206 - 206
Опубликована: Янв. 25, 2024
Background
and
Objectives:
Menstrual
changes,
including
altered
cycle
length
bleeding
patterns,
have
been
reported
following
COVID-19
vaccination.
This
study
aimed
to
determine
the
prevalence
types
of
menstrual
changes
occurring
after
vaccination
among
female
students
staff
at
a
university
in
Saudi
Arabia.
Materials
Methods:
A
cross-sectional
was
conducted
women
aged
18–39
years
who
received
least
one
dose
vaccine.
Eligible
participants,
staff,
were
recruited
between
May
2022
November
2022.
Participants
completed
questionnaire
detailing
their
sociodemographic
characteristics,
general
medical
reproductive
history,
characteristics
before
The
various
(cycle
length,
days,
flow,
mid-cycle
spotting)
calculated.
demographic
factors
associated
with
analyzed
using
chi-squared
tests.
Results:
472
included
participants
had
mean
age
20.9
years,
95.3%
unmarried.
Changes
by
54.7%
respondents
overall.
most
common
change
followed
number
menstruation
days
flow.
not
age,
BMI,
occupation,
marital
status,
or
history.
intermenstrual
more
frequently
third
Pfizer
vaccine
compared
Moderna
(p
=
0.014).
Conclusions:
More
than
half
vaccination,
being
common.
potential
underlying
mechanisms
implications
these
alterations
require
further
investigation.
These
findings
provide
evidence
side
effects
vaccines
Frontiers in Drug Safety and Regulation,
Год журнала:
2024,
Номер
4
Опубликована: Янв. 31, 2024
Introduction:
Menstrual
disorders
are
commonly
reported
after
COVID-19
vaccination
and
heavy
menstrual
bleeding
was
added
to
the
product
information
of
vaccines
Moderna
Pfizer.
The
aim
this
review,
using
a
systematic
search,
is
provide
an
overview
available
literature
on
risk
vaccination.
Methods:
review
conducted
according
Preferred
Reporting
Items
for
Systematic
reviews
Meta-Analysis
(PRISMA)
guidelines.
A
PubMed
search
performed
15
August
2023,
including
solely
quantitative
studies
in
English
Dutch.
Results:
total
61
were
included,
which
40
cross-sectional
studies,
18
cohort
three
self-controlled
case
series.
Outcomes
included
wide
variety
disorders,
changes
cycle
length
(
n
=
54),
amount
44),
menses
30),
experience
(pre)menstrual
pain
21),
breakthrough
18).
All
found
higher
percentage
at
least
one
disorder
first
different
types
doses.
Discussion:
In
conclusion,
evidence
suggests
that
may
cause
women
reproductive
age.
However,
there
need
more
longitudinal
because
important
limitations
study
designs
many
studies.
Although
short-lived
predominantly
mild,
it
healthcare
professionals
be
informed
about
these
potential
adverse
reactions
assess
events
clinical
trials
vaccines.
